EU5 Metered Dose Inhaler Devices Market Outlook to 2023

  • ID: 4342774
  • Report
  • 114 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
EU5 Metered Dose Inhaler Devices Market Outlook to 2023

Summary

The new report, "EU5 Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the EU5 Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the EU5 Metered Dose Inhaler Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Metered Dose Inhaler Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Metered Dose Inhaler Devices Market, EU5
3.1 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2023
3.2 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2016
3.3 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2016-2023
3.4 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023
3.5 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2016
3.6 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2016-2023
3.7 Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), 2016
4 Metered Dose Inhaler Devices Market, France
4.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016
4.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023
4.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016
4.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023
4.5 Metered Dose Inhaler Devices Market, France, Average Price ($), 2009-2023
4.6 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016
4.7 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016
5 Metered Dose Inhaler Devices Market, Germany
5.1 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016
5.2 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023
5.3 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016
5.4 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023
5.5 Metered Dose Inhaler Devices Market, Germany, Average Price ($), 2009-2023
5.6 Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016
5.7 Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016
6 Metered Dose Inhaler Devices Market, Italy
6.1 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2009-2016
6.2 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2016-2023
6.3 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2009-2016
6.4 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2016-2023
6.5 Metered Dose Inhaler Devices Market, Italy, Average Price ($), 2009-2023
6.6 Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), 2015-2016
6.7 Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, Spain
7.1 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, Spain, Average Price ($), 2009-2023
7.6 Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), 2015-2016
7.7 Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), 2016
8 Metered Dose Inhaler Devices Market, United Kingdom
8.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016
8.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023
8.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016
8.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023
8.5 Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), 2009-2023
8.6 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
8.7 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
9 Overview of Key Companies in EU5 Metered Dose Inhaler Devices Market
9.1 GlaxoSmithKline Plc
9.1.1 Company Overview
9.2 AstraZeneca Plc
9.2.1 Company Overview
9.3 Boehringer Ingelheim GmbH
9.3.1 Company Overview
9.4 Pfizer Inc
9.4.1 Company Overview
9.5 Merck & Co Inc
9.5.1 Company Overview
10 Metered Dose Inhaler Devices Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy
11.1.2 May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors
11.1.3 Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
11.1.4 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device
11.1.5 Mar 06, 2017: Vectura Group: Board Change
11.1.6 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting
11.1.7 Dec 14, 2016: Consort Medical: Directorate Change
11.1.8 Nov 25, 2016: Consort Medical: CFO Appointment
11.1.9 Aug 17, 2016: Consort Medical Announces Directorate Change
11.2 Financial Announcements
11.2.1 Jun 15, 2017: Consort Medical: Full year results
11.2.2 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease
11.2.3 May 10, 2017: Mylan Reports First Quarter 2017 Results
11.2.4 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
11.2.5 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center
11.2.6 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim
11.2.7 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics’ Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care
11.2.8 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016
11.2.9 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016
11.2.10 Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance
11.2.11 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback
11.2.12 Dec 06, 2016: Consort Medical Reports Interim Results For The Six Months Ended 31 October 2016
11.2.13 Nov 09, 2016: Mylan Reports Third Quarter 2016 Results
11.2.14 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
11.2.15 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8%
11.2.16 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects
11.3 Other Significant Developments
11.3.1 Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products
11.3.2 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
11.3.3 Jan 26, 2017: Achievement of sales milestone for COPD products
11.3.4 Jan 11, 2017: Vectura Group: Pre-close update
11.3.5 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda
11.3.6 Sep 07, 2016: New Scale-Up and Commercial Supply Agreement
11.3.7 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023
Table 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016
Table 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023
Table 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023
Table 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016
Table 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023
Table 7: Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), USD Constant, 2016
Table 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016
Table 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023
Table 12: Metered Dose Inhaler Devices Market, France, Average Price ($), Historic, 2009-2016
Table 13: Metered Dose Inhaler Devices Market, France, Average Price ($), Forecast, 2016-2023
Table 14: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 15: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 16: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 17: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 18: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
Table 19: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Table 20: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Historic, 2009-2016
Table 21: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Forecast, 2016-2023
Table 22: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 23: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 24: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016
Table 25: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 26: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016
Table 27: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023
Table 28: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Historic, 2009-2016
Table 29: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Forecast, 2016-2023
Table 30: Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016
Table 35: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023
Table 36: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Historic, 2009-2016
Table 37: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Forecast, 2016-2023
Table 38: Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 39: Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2016
Table 40: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 43: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 44: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016
Table 45: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023
Table 46: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 47: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 48: Metered Dose Inhaler Devices Market Pipeline Products

List of Figures
Figure 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023
Figure 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016
Figure 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023
Figure 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023
Figure 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016
Figure 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023
Figure 7: Metered Dose Inhaler Devices Market, EU5, Company Share (%) 2016
Figure 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016
Figure 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023
Figure 12: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016
Figure 13: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
Figure 16: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 17: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016
Figure 18: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 19: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 20: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016
Figure 21: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023
Figure 22: Metered Dose Inhaler Devices Market, Italy, Company Share (%) 2016
Figure 23: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016
Figure 26: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023
Figure 27: Metered Dose Inhaler Devices Market, Spain, Company Share (%) 2016
Figure 28: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 29: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 30: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 31: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 32: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Merck & Co Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll